Why Merus N.V. (MRUS) Crashed On Wednesday
We recently published a list of Investors Are Dumping These 10 Stocks.
Posts Tagged ‘NASDAQ:MRUS’
BofA Maintains Buy Rating on Merus (MRUS), Lifts PT
The decision follows Merus' highly favorable Phase 2 trial results for the combination of petosemtamab and pembrolizumab in treating first-line head and neck squamous cell carcinoma...
Merus (MRUS) Price Target Raised at BMO After Positive Phase 2 Data
The revision comes after encouraging Phase 2 data for Merus' drug candidates petosemtamab and pembrolizumab (pembro) were released.
10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
10 Best High Short Interest Stocks to Buy Now
Aditya Bhave, BofA Securities head of US Economics, joined 'Power Lunch' on CNBC on April 17 to talk about whether tariffs are ultimately inflationary, disinflationary, or deflationary...
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Jim Cramer Stocks to Watch in 2025
Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” because when the stocks rise no one would remember...
Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight
Jim Cramer, host of Mad Money, recently discussed the outlook for the stock market following a year of strong gains, cautioning that investors’ overly optimistic expectations...
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
10 Top Performing European Stocks Heading into 2025
As per Deloitte, inflation in the Eurozone slightly rebounded in October but was still quite low.
TimesSquare Capital Management U.S. Small Cap Growth Strategy Established a Position in Merus N.V. (MRUS)
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter.
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
Top 10 ADR Stocks To Buy According to Hedge Funds
Diversifying an investment portfolio is one of the best ways of spreading risk and minimizing the impact of heightened volatility.
5 Best Booming Stocks to Buy Right Now
This article presents an overview of the 5 Best Booming Stocks to Buy Right Now. For a detailed overview of such stocks, read our article, 13 Best Booming Stocks to Buy Right...
15 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the 15 top performing European stocks so far in 2024.
5 Cash-Rich Small Cap Stocks To Invest In
Needham analyst Ami Fadia initiated coverage of Cogent Biosciences with a Buy rating and $24 price target on December 14.
14 Small-Cap Stocks with High Potential
Small-cap investors took a beating in 2022 as data shows that small-cap stocks are near their all-time lows.
Hedge Fund and Insider Trading News: Neil Woodford, Leon Cooperman, Viking Global Investors, Discovery Capital Management, Schonfeld Strategic Advisors, Stitch Fix Inc (SFIX), Paychex, Inc. (PAYX), and More
Fallen-star fund manager Neil Woodford has seemingly given up his attempt to return to the UK fund management market.
3 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we will discuss the top 3 stocks to buy according to Devesh Gandhi’s SilverArc Capital.
5 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Where Do Hedge Funds Stand On Merus N.V. (MRUS)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Crazy About Merus N.V. (MRUS)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity...
Is MRUS A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Here is What Hedge Funds Think About Merus N.V. (MRUS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On Merus N.V. (MRUS)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Have Never Been More Bullish On Merus N.V. (MRUS)
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Is Merus N.V. (MRUS) Going to Burn These Hedge Funds?
Does Merus N.V. (NASDAQ:MRUS) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company.
Baker Bros. Opened Positions In These 5 Healthcare Stocks
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000.
